Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Interventional Image Guided Systems Market: By Products, By Modality, By Type, By End-user By Application, and Region Forecast 2019-2030
The interventional image guided systems market size was valued at US$ 8,327.1 million in 2023 and is projected to reach a value of US$ 14,087.2 million by 2030, at a CAGR of 7.8% from 2024-2030. Moreover, the U.S. interventional image guided systems market is projected to grow significantly, reaching an estimated value of US$ xx billion by 2032.
Growing demand for minimally invasive procedures, new advancements in imaging and navigation technology, and an increase in prevalence of chronic diseases are driving the market. However, high costs, complex regulatory hurdles, and the need for specialized training make it a barrier to entry. The growth opportunities lie in emerging markets with expanding health care infrastructure and greater integration of AI and machine learning for higher accuracy, as well as more robust safety arrangements for patients. As health care matures, such factors will define its eventual directions in these markets.
GE Healthcare, Olympus, Philips Healthcare, Siemens Healthineers, and Toshiba Medical Systems are some of the major companies in the market. St. Jude Medical and Neusoft take considerable shares as well along with those of Konica Minolta and Samsung Medison. Shimadzu, BenQ Medical Technology, and Asahi Roentgen also have their existence in this competitive field. Other such companies would include Mindray, Bruker, Dentsply Sirona, Sofie Biosciences, and Sonoita, which have introduced new innovations and improvements in the interventional procedures and are improving it even more.
By Products: This is led by the bi-plane systems, as they offer better imaging, giving the chance to have a better view of very complex anatomical structures during procedures. T Single plane systems are, however still in use due to their utilization in simpler procedures, while demand for much more minimally invasive techniques and higher efficiency demands by procedurally make an entry into bi-planed ones, which are preferred to be used by more healthcare professionals.
By Modality: The vascular interventional systems based on the prevalent nature of cardiovascular diseases around the world and their core role in diagnosing and treating them manage to dominate the market. These systems enable a "minimally invasive procedure" to improve the patient outcomes and reduce recovery time. Not far behind are fluoroscopy systems, offering real-time imaging for interventions. Other noteworthy imaging solutions for the surgical process include intraoperative ultrasound scanners and endoscopes. Although intraoperative CT and MRI scanners represent advanced imaging modalities, their cost requires that they be considered less established than the prevailing vascular systems.
By Type: In the market, X-ray fluoroscopy image-guided systems hold the top spot because of widespread usage and high performance in providing real-time imaging in various minimally invasive procedures. Fluoroscopic systems are preferred because they allow imaging of dynamic procedures inside the body, particularly in vascular interventions. Following fluoroscopy, the ultrasound image-guided systems occupy the second-largest market share, primarily because of portability and safety. These systems find wide acceptance in many settings. CT image-guided systems are also very crucial in oncology for the localization and treatment of tumors. MRI, PET, and SPECT systems play a key role in specialized applications but the relatively higher price and longer time to setup limit their usability in general interventional procedures. The overall requirements of real-time and effective imaging have enabled preference for X-ray fluoroscopy systems in this market space.
By Application: Growth in the market is mainly driven by the cardiology segment because cardiovascular diseases are rampant among a large proportion of the global population, and there has been a rise in the popularity of minimally invasive procedures such as angioplasty and stenting. Advanced image guidance technologies play a crucial role in cardiology because imaging is an essential step for proper diagnosis and treatment planning. The oncology segment is also highly potential because cancer is on the rise among people, which requires exact determination of the location of the tumors and targeted therapies. After these, neurology is the upcoming key application, especially in procedures such as biopsies and tumor resections. Urology, gastroenterology, gynecology, and orthopedics further drive the market growth with improved imaging outcomes in these areas.
By End user: Hospitals are the largest end-user segment in the market, mainly due to the sophisticated infrastructure of the hospitals and the large number of complex procedures performed. Advanced technologies and a diversified range of specialists make hospitals a crucial entity for interventional procedures. Indeed, there is increasing importance of ambulatory surgical centers on their own, for instance, because outpatient surgery and minimally invasive procedures that may be carried out on an ambulatory surgical center are generally less invasive, and thus they lead to fewer complications and quick recovery times. Diagnostic centers also have a significant role in most of the imaging-guided procedures, even though they tend to perform less complex interventions than a hospital. Clinics have the chance to cater to some of the specific demands but are a relatively minor part of the market because they are limited in their ability to carry out complex interventional procedures.
Study Period
2024-2030Base Year
2023CAGR
7.8%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The major driver for the market is growth in demand for minimally invasive procedures, such as those that entail fewer complications, shorter recovery times, and cause less discomfort to patients. Technological advancement, particularly in the area of imaging and navigation systems, is improving the level of precision in the performance and safety of interventional procedures. On the other hand, an increase in the prevalence of chronic diseases, such as cardiovascular diseases and cancer, is also multiplying the need for effective diagnostic and treatment options.
Although this market still offers a lot of room for expansion, there are several challenges to the market. Advanced technologies are precluded by the cost barrier to participation; it is usually unaffordable for smaller facilities. Complex regulatory problems prevail, including difficulties in the introduction of systems whose compliance has been hard to manage. Training skills in operating sophisticated equipment also have limited usage for these technologies.
In the case of interventional-guided systems, some of the important growth opportunities will be emerging markets where infrastructure will grow rapidly. Artificial intelligence and machine learning in guided systems would improve the accuracy of diagnostics and procedural efficiency of the practitioners. Improved patient safety and comfort along with innovations relating to remote guidance and telemedicine is likely to increase demand for advanced interventional solutions.
Some key trends impacting the systems market include growing telemedicine, enabling remote guidance during procedures and rising wearable technologies to monitor the real-time process. Adopting a patient-centric approach, the focus has shifted towards a more holistic experience and better outcomes. Ecological and green practices in the manufacture of medical devices are also becoming increasingly important nowadays. This reflects an environmental accountability in the healthcare stream.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 8,327.1 million |
Market Size in 2030 |
US$ 14,087.2 million |
Market CAGR |
7.8% |
By Product |
|
By Modality |
|
By Type |
|
By End User |
|
By End User |
|
By Region |
|
The market is expanding at a healthy rate with the growing demand for minimally invasive procedures and improving imaging technologies. The largest end-users, in particular hospitals, now capitalize on the need for accurate diagnostics and efficient treatment options. However, hospitals do face issues like high costs, specialized training requirements, and treatment complications, especially in cardiology and oncology. Expansion opportunity exists in emerging markets with improving health access and in integrations involving AI and robotics to create better procedural outcomes. Generally, the market has been set up for a bright future with this: The market will continue with innovations indefinitely. Its gradual drift towards patient-centric care largely characterizes the future of the market.
Download Free Sample Report
Interventional image guided systems market size was valued at US$ 8,327.1 Mn in 2023 and is set to reach value of US$ 14,087.2 Mn by 2030, CAGR of 7.8%.
Applications include cardiology, oncology, neurology, urology, gastroenterology, gynecology, and orthopedics. All of these applications have their need for accurate imaging technologies which allow patients to receive the most effective treatments.
The key drivers here are an increasing demand for minimally invasive techniques, advancement of image and navigation technologies, higher incidences of chronic diseases, increased focus on patient safety and recovery.
The market faces challenges such as high cost of advanced technologies, complexity of regulatory requirements, needs of specialized training, and resistance of healthcare providers to change
Hospitals are the biggest consumers, as they can facilitate sophisticated procedures and superior technology. Ambulatory surgical centers focus on outpatient procedures, which are done more efficiently and rapidly, and are increasingly adopting the interventional guided system.
It is the advanced technology applied to help healthcare professionals while making minimally invasive procedures more accurate and safer by showing and navigating them in real-time.
1.Executive Summary |
2.Global Interventional Image Guided Systems Market Introduction |
2.1.Global Interventional Image Guided Systems Market - Taxonomy |
2.2.Global Interventional Image Guided Systems Market - Definitions |
2.2.1.Product |
2.2.2.Modality |
2.2.3.Type |
2.2.4.End User |
2.2.5.Region |
3.Global Interventional Image Guided Systems Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Interventional Image Guided Systems Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Interventional Image Guided Systems Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. Single Plane |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Bi-Plane Systems |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Interventional Image Guided Systems Market By Modality, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Vascular interventional systems |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Intraoperative ultrasound scanner |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Fluoroscopy |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Intraoperative CT scanner |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Endoscope’s systems |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Intraoperative MRI scanner |
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Others |
6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
7.Global Interventional Image Guided Systems Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. CT image-guided systems |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. MRI image-guided systems |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. X-ray fluoroscopy image-guided systems |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. PET image-guided systems |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Endoscope image-guided systems |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Ultrasound image-guided systems |
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
7.7. SPECT image-guided systems |
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.7.3. Market Opportunity Analysis |
7.8. Others |
7.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.8.3. Market Opportunity Analysis |
8.Global Interventional Image Guided Systems Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. Cardiology |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Neurology |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Oncology |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Urology |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Gastroenterology |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Gynecology |
8.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.6.3. Market Opportunity Analysis |
8.7. Orthopedics |
8.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.7.3. Market Opportunity Analysis |
9.Global Interventional Image Guided Systems Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Interventional Image Guided Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Single Plane |
10.1.2.Bi-Plane Systems |
10.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Vascular interventional systems |
10.2.2.Intraoperative ultrasound scanner |
10.2.3.Fluoroscopy |
10.2.4.Intraoperative CT scanner |
10.2.5.Endoscope’s systems |
10.2.6.Intraoperative MRI scanner |
10.2.7.Others |
10.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.CT image-guided systems |
10.3.2.MRI image-guided systems |
10.3.3.X-ray fluoroscopy image-guided systems |
10.3.4.PET image-guided systems |
10.3.5.Endoscope image-guided systems |
10.3.6.Ultrasound image-guided systems |
10.3.7.SPECT image-guided systems |
10.3.8.Others |
10.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Cardiology |
10.4.2.Neurology |
10.4.3.Oncology |
10.4.4.Urology |
10.4.5.Gastroenterology |
10.4.6.Gynecology |
10.4.7.Orthopedics |
10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Interventional Image Guided Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Single Plane |
11.1.2.Bi-Plane Systems |
11.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Vascular interventional systems |
11.2.2.Intraoperative ultrasound scanner |
11.2.3.Fluoroscopy |
11.2.4.Intraoperative CT scanner |
11.2.5.Endoscope’s systems |
11.2.6.Intraoperative MRI scanner |
11.2.7.Others |
11.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.CT image-guided systems |
11.3.2.MRI image-guided systems |
11.3.3.X-ray fluoroscopy image-guided systems |
11.3.4.PET image-guided systems |
11.3.5.Endoscope image-guided systems |
11.3.6.Ultrasound image-guided systems |
11.3.7.SPECT image-guided systems |
11.3.8.Others |
11.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Cardiology |
11.4.2.Neurology |
11.4.3.Oncology |
11.4.4.Urology |
11.4.5.Gastroenterology |
11.4.6.Gynecology |
11.4.7.Orthopedics |
11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
12.Asia Pacific (APAC) Interventional Image Guided Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Single Plane |
12.1.2.Bi-Plane Systems |
12.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Vascular interventional systems |
12.2.2.Intraoperative ultrasound scanner |
12.2.3.Fluoroscopy |
12.2.4.Intraoperative CT scanner |
12.2.5.Endoscope’s systems |
12.2.6.Intraoperative MRI scanner |
12.2.7.Others |
12.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.CT image-guided systems |
12.3.2.MRI image-guided systems |
12.3.3.X-ray fluoroscopy image-guided systems |
12.3.4.PET image-guided systems |
12.3.5.Endoscope image-guided systems |
12.3.6.Ultrasound image-guided systems |
12.3.7.SPECT image-guided systems |
12.3.8.Others |
12.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Cardiology |
12.4.2.Neurology |
12.4.3.Oncology |
12.4.4.Urology |
12.4.5.Gastroenterology |
12.4.6.Gynecology |
12.4.7.Orthopedics |
12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Interventional Image Guided Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Single Plane |
13.1.2.Bi-Plane Systems |
13.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Vascular interventional systems |
13.2.2.Intraoperative ultrasound scanner |
13.2.3.Fluoroscopy |
13.2.4.Intraoperative CT scanner |
13.2.5.Endoscope’s systems |
13.2.6.Intraoperative MRI scanner |
13.2.7.Others |
13.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.CT image-guided systems |
13.3.2.MRI image-guided systems |
13.3.3.X-ray fluoroscopy image-guided systems |
13.3.4.PET image-guided systems |
13.3.5.Endoscope image-guided systems |
13.3.6.Ultrasound image-guided systems |
13.3.7.SPECT image-guided systems |
13.3.8.Others |
13.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Cardiology |
13.4.2.Neurology |
13.4.3.Oncology |
13.4.4.Urology |
13.4.5.Gastroenterology |
13.4.6.Gynecology |
13.4.7.Orthopedics |
13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Interventional Image Guided Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
14.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Single Plane |
14.1.2.Bi-Plane Systems |
14.2. Modality Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Vascular interventional systems |
14.2.2.Intraoperative ultrasound scanner |
14.2.3.Fluoroscopy |
14.2.4.Intraoperative CT scanner |
14.2.5.Endoscope’s systems |
14.2.6.Intraoperative MRI scanner |
14.2.7.Others |
14.3. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.CT image-guided systems |
14.3.2.MRI image-guided systems |
14.3.3.X-ray fluoroscopy image-guided systems |
14.3.4.PET image-guided systems |
14.3.5.Endoscope image-guided systems |
14.3.6.Ultrasound image-guided systems |
14.3.7.SPECT image-guided systems |
14.3.8.Others |
14.4. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Cardiology |
14.4.2.Neurology |
14.4.3.Oncology |
14.4.4.Urology |
14.4.5.Gastroenterology |
14.4.6.Gynecology |
14.4.7.Orthopedics |
14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.GE Healthcare |
15.2.2.Olympus, |
15.2.3.Philips Healthcare |
15.2.4.Siemens Healthineers |
15.2.5.Toshiba Medical Systems |
15.2.6.St. Jude Medical |
15.2.7.Neusoft |
15.2.8.Konica Minolta |
15.2.9.Samsung Medison |
15.2.10.Shimadzu, |
15.2.11.BenQ Medical Technology |
15.2.12.Asahi Roentgen |
15.2.13.Mindray |
15.2.14.Bruker |
15.2.15.Dentsply Sirona |
15.2.16.Sofie Biosciences |
15.2.17.Sonoita |
16. Research Methodology |
17. Appendix and Abbreviations |